Targeting intracellular oncoproteins with antibody therapy or vaccination
10.1126/scitranslmed.3002296
Saved in:
Main Authors: | Guo, K., Li, J., Tang, J.P., Tan, C.P.B., Hong, C.W., Al-Aidaroos, A.Q.O., Varghese, L., Huang, C., Zeng, Q. |
---|---|
Other Authors: | INSTITUTE OF MOLECULAR & CELL BIOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/115312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
by: Guo, K., et al.
Published: (2014) -
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
by: Guo, Ke, et al.
Published: (2021) -
Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
by: Guo, Ke, et al.
Published: (2013) -
PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014) -
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
by: Thura M., et al.
Published: (2020)